Sepsis is a major health problem in newborns and children. Early detection of pathogens allows initiation of appropriate antimicrobial therapy that strongly correlates with positive outcomes. Multiplex PCR has the potential to rapidly identify bloodstream infections, compensating for the loss of blood culture sensitivity. In an Italian pediatric hospital, multiplex PCR (the LightCycler SeptiFast test) was compared to routine blood culture with 1,673 samples obtained from 803 children with suspected sepsis; clinical and laboratory information was used to determine the patient infection status. Excluding results attributable to contaminants, SeptiFast showed a sensitivity of 85.0% (95% confidence interval [CI] ؍ 78.7 to 89.7%) and a specificity of 93.5% (95% CI ؍ 92.1 to 94.7%) compared to blood culture. The rate of positive results was significantly higher with SeptiFast (14.6%) than blood culture (10.3%) (P < 0.0001), and the overall positivity rate was 16.1% when the results of both tests were combined. Staphylococcus aureus (11.6%), coagulase-negative staphylococci (CoNS) (29.6%), Pseudomonas aeruginosa (16.5%), and Klebsiella spp. (10.1%) were the most frequently detected. SeptiFast identified 97 additional isolates that blood culture failed to detect (24.7% P. aeruginosa, 23.7% CoNS, 14.4% Klebsiella spp., 14.4% Candida spp.). Among specimens taken from patients receiving antibiotic therapy, we also observed a significantly higher rate of positivity of SeptiFast than blood culture (14.1% versus 6.5%, respectively; P < 0.0001). On the contrary, contaminants were significantly more frequent among blood cultures than SeptiFast (n ؍ 97 [5.8%] versus n ؍ 26 [1.6%]), respectively; P < 0.0001). SeptiFast served as a highly valuable adjunct to conventional blood culture in children, adding diagnostic value and shortening the time to result (TTR) to 6 h.Pediatric patients with severe trauma and burns, immunodeficiency, malignancy, and prematurity have an increased incidence of septicemia with a high case fatality rate (10 to 50%) (10). Moreover, prolonged hospitalization, broad-spectrum empirical antimicrobial therapy, and supportive care have a strong impact on the cost of care (15,25).Oncohematological patients and newborns, particularly preterm infants, are at high risk for severe infections and sepsis due to their deficient and/or immature immunologic defense (5, 7). Rapid detection of the infectious cause and prompt initiation of appropriate antimicrobial treatment are fundamental for the successful treatment of septic patients and for the reduction of antibiotic resistance rates (23, 30).Blood culture is the current "gold standard" for the detection of bloodstream microbial pathogens; although it allows microbes to be identified and their susceptibility profiles to be tested, it presents several limitations. Lack of rapidity is a major problem: detection of bacterial growth requires approximately 12 to 48 h or more in the case of fastidious bacterial or invasive fungal infection (1, 18). Another remarka...